- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
MCAM Antibody 4C12 recognizes melanoma cell adhesion molecule (MCAM), a cell surface glycoprotein belonging to the immunoglobulin superfamily. Also known as CD146, MUC18, and Mel-CAM, this protein is encoded by the MCAM gene on human chromosome 11. Originally identified as a melanoma-associated antigen, MCAM is now recognized as an important adhesion molecule involved in vascular biology, cell migration, and interactions between neighboring cells. Its expression in normal and malignant tissues makes it relevant to research investigating endothelial function, tumor progression, and cellular differentiation.
MCAM is a type I transmembrane protein containing five extracellular immunoglobulin-like domains, a membrane-spanning region, and a cytoplasmic tail. Extensive glycosylation contributes to its relatively high apparent molecular weight, which can vary between approximately 70 and 120 kDa depending on the cellular source and glycosylation state. Alternative splicing generates isoforms with different cytoplasmic regions that may influence intracellular signaling and cellular localization. These structural characteristics enable MUC18 to participate in cell adhesion and communication with the surrounding microenvironment.
CD146 is expressed by vascular endothelial cells, smooth muscle cells, pericytes, and subsets of mesenchymal stromal cells. It has been investigated as a marker of endothelial lineage and as a participant in vascular development and angiogenesis. MCAM expression is also reported in selected immune cell populations, including activated T lymphocytes, where it may contribute to cellular migration and interactions with vascular tissues.
In melanoma research, MCAM expression has been associated with increased cellular motility, invasive behavior, and metastatic potential. Experimental studies suggest that CD146 can influence signaling pathways involved in cytoskeletal organization, cell survival, and interactions with the extracellular matrix. Expression of MUC18 has also been reported in several other malignancies, although its biological significance varies with tumor type and cellular context.
Because MCAM is present in both normal vascular tissues and certain tumors, its detection can help characterize patterns of cell surface protein expression and investigate changes associated with cellular differentiation or disease. Western blotting can be used to examine MCAM protein abundance and glycosylation-dependent migration, while immunohistochemistry and flow cytometry provide complementary information about tissue distribution and cell surface expression.
An MCAM Antibody 4C12 from NSJ Bioreagents supports investigations of MUC18 expression, endothelial cell biology, melanoma-associated adhesion mechanisms, and the regulation of cellular migration.
For an alternative antibody targeting the same cell adhesion molecule, see our MCAM Antibody MCAM/3046, a mouse monoclonal antibody featuring human melanoma IHC and protein microarray specificity validation.
Optimal dilution of the MCAM Antibody 4C12 / MUC18 Antibody should be determined by the researcher.
Recombinant human protein (amino acids H59-A401) was used as the immunogen for the MCAM Antibody 4C12.
After reconstitution, the MCAM Antibody 4C12 can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
CD146 antibody, MUC18 antibody, Melanoma Cell Adhesion Molecule antibody, Mel-CAM antibody, Cell Surface Glycoprotein MUC18 antibody, CD146 Antigen antibody, Melanoma Adhesion Molecule antibody, MCAM Protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.